S. Matthaei

H. Häring, M. Dreyer, S. Matthaei, 2005, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Insulin-mediated pseudoacromegaly in a patient with severe insulin resistance: association of defective insulin-stimulated glucose transport with impaired phosphatidylinositol 3-kinase activity in fibroblasts.

A. Hamann, C. Kausch, S. Matthaei, 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Analysis of the uncoupling protein-1 (UCP1) gene in obese and lean subjects: Identification of four amino acid variants

H. Münzberg, J. Hebebrand, A. Hinney, 1998, International Journal of Obesity.

Acquired generalized lipoatrophy (AGL): Highly selective MR lipid imaging and localized 1H‐MRS

F. Schick, C. Claussen, S. Jacob, 2000, Journal of magnetic resonance imaging : JMRI.

Regulation of energy balance by leptin.

A. Hamann, S. Matthaei, 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[Progress in obesity research].

A. Hamann, S. Matthaei, 1997, Medizinische Monatsschrift fur Pharmazeuten.

The relationship between insulin binding, insulin activation of insulin-receptor tyrosine kinase, and insulin stimulation of glucose uptake in isolated rat adipocytes. Effects of isoprenaline.

H. Klein, S. Matthaei, P. Scriba, 1991, The Biochemical journal.

Pathophysiology and pharmacological treatment of insulin resistance.

M. Stumvoll, H. Häring, S. Matthaei, 2000, Endocrine reviews.

Computational Modelling of Fuel Motion and Its Interaction with the Reservoir Structure

S. Matthaei, H. Müllerschön, M. Vesenjak, 2017 .

A Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagli ﬂ ozin Plus Metformin in Patients With Type 2 Diabetes

S. Matthaei, N. Iqbal, B. Hirshberg, 2015 .

Biochemical characterization and subcellular distribution of the glucose transporter from rat brain microvessels.

J. Olefsky, S. Matthaei, R. Horuk, 1987, Biochimica et biophysica acta.

Prolonged plasma half-life of insulin in patients with a genetic defect of high affinity binding sites.

H. Rüdiger, S. Matthaei, M. Dreyer, 1986, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Intense cholesterol lowering therapy with a HMG-CoA reductase inhibitor does not improve nitric oxide dependent endothelial function in type-2-diabetes--a multicenter, randomised, double-blind, three-arm placebo-controlled clinical trial.

T. Wascher, H. Häring, S. Matthaei, 2005, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Effect of in vivo thyroid hormone status on insulin signalling and GLUT1 and GLUT4 glucose transport systems in rat adipocytes.

H. Klein, H. Benecke, A. Hamann, 1995, The Journal of endocrinology.

Glucose and insulin co-regulate the glucose transport system in primary cultured adipocytes. A new mechanism of insulin resistance.

J. Olefsky, S. Matthaei, W. Garvey, 1987, The Journal of biological chemistry.

Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study

Peter Bramlage, S. Matthaei, W. Zidek, 2012, Cardiovascular Diabetology.

Tailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management

J. Lasalle, S. Matthaei, C. Bailey, 2010, International journal of clinical practice.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study

C. Östenson, C. Mathieu, S. Matthaei, 2013, Health and Quality of Life Outcomes.

First-line antihypertensive treatment in patients with pre-diabetes: Rationale, design and baseline results of the ADaPT investigation

S. Matthaei, W. Zidek, C. Hasslacher, 2008, Cardiovascular diabetology.

Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study

C. Östenson, C. Mathieu, S. Matthaei, 2013, ClinicoEconomics and outcomes research : CEOR.

One‐year efficacy and safety of saxagliptin add‐on in patients receiving dapagliflozin and metformin

S. Matthaei, N. Iqbal, P. García-Hernández, 2016, Diabetes, obesity & metabolism.

Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance.

S. Jacob, H. Häring, S. Matthaei, 2000, Circulation.

Dapagliflozin Improves Glycemic Control and Reduces Body Weight as Add-on Therapy to Metformin Plus Sulfonylurea: A 24-Week Randomized, Double-Blind Clinical Trial

S. Matthaei, K. Bowering, S. Parikh, 2015, Diabetes Care.

Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes

S. Matthaei, N. Iqbal, B. Hirshberg, 2015, Diabetes Care.

Using Exenatide Twice Daily or Insulin in Clinical Practice: Results from CHOICE

C. Östenson, C. Mathieu, S. Matthaei, 2013, Diabetes Therapy.

Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries

C. Östenson, C. Mathieu, S. Matthaei, 2013, Diabetes, metabolic syndrome and obesity : targets and therapy.

Individualized glycaemic targets and pharmacotherapy in type 2 diabetes

J. Lasalle, S. Del Prato, S. Matthaei, 2013, Diabetes & vascular disease research.

Medical Antihyperglycaemic Treatment of Type 2 Diabetes Mellitus*

H. Joost, A. Fritsche, S. Matthaei, 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Gaps and barriers in the control of blood glucose in people with type 2 diabetes

Lawrence A Leiter, L. Blonde, S. Matthaei, 2017, Diabetes & vascular disease research.

Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects.

F. Schick, C. Claussen, J. Machann, 1999, Diabetes.

In vivo metformin treatment ameliorates insulin resistance: evidence for potentiation of insulin-induced translocation and increased functional activity of glucose transporters in obese (fa/fa) Zucker rat adipocytes.

H. Klein, H. Benecke, H. Häring, 1993, Endocrinology.

Oxygen consumption and resting metabolic rate in sepsis, sepsis syndrome, and septic shock

S. Matthaei, P. Buggisch, H. Greten, 1993, Critical care medicine.

Metformin

M. Stumvoll, H. Häring, S. Matthaei, 2007, Reactions weekly.

Macroeconomic implications of the German financial equalization system

S. Matthaei, Nikolai Stähler, 2016 .

Insulin receptor kinase following internalization in isolated rat adipocytes.

H. Klein, J. Olefsky, S. Matthaei, 1987, The Journal of biological chemistry.

The relationship between insulin binding, insulin activation of insulin-receptor tyrosine kinase, and insulin stimulation of glucose uptake in isolated rat adipocytes

H. Klein, S. Matthaei, P. Scriba, 1991 .

Type I hyperlipoproteinemia due to a novel loss of function mutation of lipoprotein lipase, Cys(239)-->Trp, associated with recurrent severe pancreatitis.

W. März, H. Häring, S. Matthaei, 2000, The Journal of clinical endocrinology and metabolism.

Screening for variability in the ciliary neurotrophic factor (CNTF) gene: No evidence for association with human obesity

H. Münzberg, J. Hebebrand, A. Hinney, 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Skeletal Muscle Cells from Insulin-resistant (Non-diabetic) Individuals are Susceptible to Insulin Desensitization by Palmitate

J. Krützfeldt, C. Kausch, S. Matthaei, 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

„Diabetes-Excellence-Center“-Initiative

S. Matthaei, M. Dreyer, A. Risse, 2011, Der Diabetologe.

Rapid and effective transfer of integral membrane proteins from isoelectric focusing gels to nitrocellulose membranes.

S. Matthaei, R. Horuk, D. Baly, 1986, Analytical biochemistry.

Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study

C. Östenson, C. Mathieu, S. Matthaei, 2012, Diabetes Therapy.

Metformin increases glucose transporter protein and gene expression in human fibroblasts.

H. Benecke, A. Hamann, S. Matthaei, 1993, Biochemical and biophysical research communications.

Evidence that metformin increases insulin-stimulated glucose transport by potentiating insulin-induced translocation of glucose transporters from an intracellular pool to the cell surface in rat adipocytes.

H. Klein, J. Flier, H. Benecke, 1992, Hormone and metabolic research. Supplement series.